Metabolic responses to tumour disease and progression: Tumour-host interaction

Clinical Nutrition

Volumn 19, Issue 6, 2000, Pages 459-465

  Cravo, M L ^a,b   Gloria L M ^a   Claro, I ^a  

^a Instituto Português De Oncologia Francisco Gentil Centro Regional De Lisboa   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Cancer cachexia; Tumour host interactions

Indexed keywords

AMINO ACID; ARACHIDONIC ACID; CYCLIC AMP; CYSTEINE; CYTOKINE; FAT; GLUCOSE; GLUTAMINE; GLYCEROL; GLYCOPROTEIN; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LEUCINE; LINOLEIC ACID; LIPOPROTEIN LIPASE; LIPOXYGENASE; NITROGEN; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE; PROTEIN; PROTEOGLYCAN; RAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANOREXIA; APOPTOSIS; ARTICLE; BODY COMPOSITION; CACHEXIA; CALORIC INTAKE; CANCER PATIENT; CATABOLISM; CONTROLLED STUDY; HUMAN; LIPOLYSIS; MEDIATOR; METABOLIC DISORDER; METABOLIC REGULATION; MITOSIS; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PROTEIN DEGRADATION; STARVATION; TUMOR CELL; TUMOR GROWTH; TUMOR PROMOTION; WASTING SYNDROME;

EID: 0033665125     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2000.0140     Document Type: Article

References (75)

1. Biology of cachexia
2. The cancer cachexia syndrome
3. The syndrome of anorexia-cachexia
4. Cancer cachexia
5. Management of cancer cachexia
6. The immediate cause of death in cancer
7. Prognostic effect of weight loss prior to chemotherapy in cancer patients
8. Effect of nutritional status on response to therapy
9. Critical evaluation of the role of nutritional support with chemotherapy
10. Nutrition support in clinical practice: Review of published data and recommendations for future research directions
11. Role of nutrition support during induction chemoradiation therapy in esophageal cancer
12. Body cell mass in cancer bearing and anorexic patients
13. Cachexia, the metabolic component of neoplastic diseases
14. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour
15. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals
16. Weight loss and cachexia in lung cancer
17. Cachexia, the metabolic component of neoplastic diseases
18. Effect of dietary counselling on food intake, body weight, response rate, survival and quality of life in patients undergoing chemotherapy: A prospective, randomized study
19. Cancer cachexia
20. Role of endogenous tumor necrosis factor α and interleukin-1 for experimental tumor growth and the development of cancer cachexia
21. Effects of tumour necrosis alpha (TNF alpha) on glucose transport and lipid metabolism of newly differentiated human fat cells in cell culture
22. Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis
23. Effect of tumor necrosis factor alpha on muscle protein turnover in female Wistar rats
24. Evidence for tumor necrosis factor/cachetin production in cancer
25. Tumor necrosis factor in children with malignancies
26. Tumors secreting human TNF/cachetin induce cachexia in mice
27. Tumour necrosis factor in man: Clinical and biological observations
28. Tumor necrosis factor not detectable in patients with clinical cancer cachexia
29. Evidence for the involvement of interleukin-6 in experimental cancer cachexia
30. Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6
31. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host
32. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentanoic acid
33. Alteration of serum and urinary lipolytic activity with weight loss in cachetic cancer patients
34. Lipolytic factors associated with murine and human cancer cachexia
35. Characterization of a cancer cachetic factor
36. Induction of muscle protein degradation by a tumour factor
37. Induction of muscle protein degradation and weight loss by a tumor product
38. Induction of cachexia in mice by a product isolated from urine of cachetic cancer patients
39. Energy expenditure in malnourished cancer patients
40. Resting energy expenditure in lung and colon cancer
41. Resting energy expenditure in malnourished patients with and without cancer
42. Uncomplicated starvation versus cancer cachexia
43. Elevated energy expenditure in cancer patients with solid tumours
44. Glucose utilization in vivo by human pulmonary neoplasms
45. Glucose metabolism in cancer cells. Isolation, sequence and activity of the promoter for type II hexokinase
46. Substrate balances across colonic carcinomas in humans
47. Metabolic substrate utilization by tumor and host tissues in cancer cachexia
48. Carbohydrate metabolism in cancer cachexia
49. Gluconeogenesis from alanine in patients with progressive malignant disease
50. Glucose turnover, gluconeogenesis from glycerol and estimation of net glucose cycling in cancer patients
51. Anorexia and weight loss in cancer patients
52. Eicosanoids and linolate-enhanced growth of mouse mammary tumor cells
53. Effect of dietary fat on growth kinetics of transplantable mammary adenocarcinoma in Balb/c mice
54. Relationships between weight loss, reduction of body cell mass and inflammatory response in patients with cancer
55. Skeletal muscle metabolism in patients with malignant tumour
56. Tumour induction of host leucine starvation
57. L-cysteine requirements of malignant cells and progress toward depletion therapy
58. Effect of methionine replacement by homocysteine on the growth of cells
59. Cachexia, gluconeogenesis and progressive weight loss in cancer patients
60. The effect of GTPase activating protein upon Ras is inhibited by mitogenically responsive lipids
61. Phospholipids containing polyunsaturated acyl groups are mitogenic for normal mouse mammary epithelial cells in serum free primary cell culture
62. Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells
63. Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo
64. Biochemical messenger
65. Arachidonate lypoxygenases as essential regulators of cell survival and apoptosis
66. Availability of glutamine from peptides and acetylglutamine for human tumor-cell lines
67. Influence of two glutamine containing dipeptides on growth of mammalian cells
68. Glutamine protects U937 cells against heat induced apoptosis in association with high expression of hsp70
69. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia
70. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model
71. The epidemiology of breast cancer: Review and prospects
72. Dietary fat, adipose tissue composition, and the development of carcinoma of the colon
73. Effect of olive oil on early and late events of colon carcinogenesis in rats: Modulation of arachidonic acid metabolism and local prostaglandin E2 synthesis
74. Effect of a cachetic factor on carbohydrate metabolism and attenuation by eicosapentanoic acid
75. The effects of an oral nutritional supplement enriched with fish oil on weight loss in patients with pancreatic cancer